COVID-19 and elective cosmetic procedures: Asymptomatic transmission in epidemic area and subsequent burdens

Abstract

Coronavirus disease 2019 (COVID-19) continues to spread rapidly across China. As of June 13, 2020, COVID-19 was reported from 213 countries globally. To date, 7 801 786 patients have been confirmed to have COVID-19, and 429 965 of them have died. COVID-19 seems to be highly contagious and has rapidly spread worldwide. Transmission before symptoms develop is infrequent, although it cannot be excluded. Furthermore, individuals who remain asymptomatic could carry the virus. Hence, isolation is the best way to fight this epidemic. The transmission occurs through respiratory droplets from coughing and sneezing. Aerosol transmission is also possible in case of elevated aerosol concentrations in closed spaces. In general, the transmission is primarily limited to family members, healthcare professionals, and other close contacts.1 In these situations, especially in hot point area, it seems that elective cosmetic procedures need extreme caution or even canceling plan with below concepts. It is notable that some cosmetic procedures have a high priority (for example skin biopsy) and others have a low priority. These procedures can categorized as a low risk procedures (for example filler injection) or high risk procedures (for example Laser therapy and those need sedation).